Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.

Publication ,  Journal Article
Storey, PP; Obeid, A; Pancholy, M; Goodman, J; Borkar, D; Su, D; Regillo, C
Published in: Retina
January 2020

PURPOSE: To report the incidence and course of ocular hypertension after intravitreal injection of 2-mg triamcinolone acetonide (IVT). METHODS: In a retrospective, consecutive series, all patients receiving 2-mg IVT at a single institution between March 1, 2012, and March 1, 2017, with a minimum of 3-month follow-up were reviewed. Ocular hypertension was defined as an intraocular pressure (IOP) measurement over 24 mmHg at any follow-up visit after IVT. Patients receiving topical, periocular, or intravitreal corticosteroid other than 2-mg IVT were excluded. RESULTS: A total of 106 eyes in 100 patients receiving at least one injection of 2-mg IVT were included. Eyes received an average of 2.9 injections (range 1-17), and average patient follow-up was 15.1 months (range 3.0-52.5 months). A total of 14 eyes (13.2%) in 14 patients developed ocular hypertension after a median of 1.5 injections (range 1-9) with an average peak IOP of 29 mmHg (range 25-38 mmHg). Overall, a total of 11 eyes (10.4%) had an IOP elevation ≥10 mmHg above baseline at any point after first IVT. In all cases of ocular hypertension, IOP was successfully managed with observation or topical IOP-lowering medication alone; no patients required surgical intervention. CONCLUSION: Ocular hypertension developed in 13.2% of eyes receiving intravitreal injection of 2-mg triamcinolone acetonide. Incidence of ocular hypertension after 2-mg IVT compares favorably with other intravitreally administered corticosteroids.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Retina

DOI

EISSN

1539-2864

Publication Date

January 2020

Volume

40

Issue

1

Start / End Page

75 / 79

Location

United States

Related Subject Headings

  • Uveitis, Posterior
  • Triamcinolone Acetonide
  • Tonometry, Ocular
  • Retrospective Studies
  • Retinal Vein Occlusion
  • Ophthalmology & Optometry
  • Ocular Hypertension
  • Middle Aged
  • Male
  • Macular Edema
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Storey, P. P., Obeid, A., Pancholy, M., Goodman, J., Borkar, D., Su, D., & Regillo, C. (2020). OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. Retina, 40(1), 75–79. https://doi.org/10.1097/IAE.0000000000002361
Storey, Philip P., Anthony Obeid, Maitri Pancholy, Jake Goodman, Durga Borkar, Daniel Su, and Carl Regillo. “OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.Retina 40, no. 1 (January 2020): 75–79. https://doi.org/10.1097/IAE.0000000000002361.
Storey PP, Obeid A, Pancholy M, Goodman J, Borkar D, Su D, et al. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. Retina. 2020 Jan;40(1):75–9.
Storey, Philip P., et al. “OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.Retina, vol. 40, no. 1, Jan. 2020, pp. 75–79. Pubmed, doi:10.1097/IAE.0000000000002361.
Storey PP, Obeid A, Pancholy M, Goodman J, Borkar D, Su D, Regillo C. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. Retina. 2020 Jan;40(1):75–79.

Published In

Retina

DOI

EISSN

1539-2864

Publication Date

January 2020

Volume

40

Issue

1

Start / End Page

75 / 79

Location

United States

Related Subject Headings

  • Uveitis, Posterior
  • Triamcinolone Acetonide
  • Tonometry, Ocular
  • Retrospective Studies
  • Retinal Vein Occlusion
  • Ophthalmology & Optometry
  • Ocular Hypertension
  • Middle Aged
  • Male
  • Macular Edema